Jeffrey Hammerbacher to Male
This is a "connection" page, showing publications Jeffrey Hammerbacher has written about Male.
Connection Strength
0.070
-
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade. Cancer Immunol Res. 2017 01; 5(1):84-91.
Score: 0.030
-
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
Score: 0.009
-
Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Rep. 2018 12 26; 25(13):3721-3732.e6.
Score: 0.009
-
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell. 2018 05 14; 33(5):843-852.e4.
Score: 0.008
-
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis. PLoS Med. 2017 05; 14(5):e1002309.
Score: 0.008
-
Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations. Sci Rep. 2016 Feb 09; 6:21161.
Score: 0.007